Michael T. Lotze

Michael T. Lotze

Corporate Officer/Principal en NURIX THERAPEUTICS, INC. .

Health Technology
Consumer Services
Health Services

Perfil

Michael T.
Lotze
is the founder of UPMC Cancer Institute.
He is currently the Chief Cellular Therapy Officer at Nurix Therapeutics, Inc. His former jobs include Director-Surgical Oncology at the University of Pittsburgh from 1990 to 2000, Vice President-Research at GlaxoSmithKline LLC, and CSO, Vice President-Research & Development at Iovance Biotherapeutics, Inc. from 2016 to 2017.
He received his doctorate degree from Northwestern University.

Cargos activos de Michael T. Lotze

EmpresasCargoInicio
NURIX THERAPEUTICS, INC. Corporate Officer/Principal 01/06/2020
Todos los cargos activos de Michael T. Lotze

Antiguos cargos conocidos de Michael T. Lotze.

EmpresasCargoFin
IOVANCE BIOTHERAPEUTICS, INC. Director Técnico/Científico/I+D 21/08/2017
University of Pittsburgh Corporate Officer/Principal 01/01/2000
Corporate Officer/Principal -
Fundador -
Ver el detalle de la experiencia de Michael T. Lotze.

Formación de Michael T. Lotze.

Northwestern University Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael T. Lotze.

Relaciones

96

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

NURIX THERAPEUTICS, INC.

Health Technology

Empresas privadas2

Health Services

Health Technology

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Michael T. Lotze